AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vistin Pharma Director's Dealing 2018

May 28, 2018

Director's Dealing

Opens in your device viewer

Mandatory notification of trade

Reference is made to the announcement today from Vistin Pharma ASA ("Vistin

Pharma") regarding the final result of the subsequent repair issue. Vegard

Heggem, VP Operations, has been allocated 10,000 new shares at a subscription

price of NOK 11.20 per share. After this transaction Vegard Heggem will

hold 27,360 shares in Vistin Pharma.